查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611903

3D 生物列印市場：按組件、技術和最終用戶分類 - 2025-2030 年全球預測

3D Bioprinting Market by Component (3D Bioprinters, Bioinks), Technology (Extrusion-based Bioprinting, Inkjet-based Bioprinting, Laser-assisted Bioprinting), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年3D生物列印市場規模為17.9億美元，預計2024年將達到21.4億美元，複合年成長率為19.89%，預計到2030年將達到63.9億美元。

3D生物列印是一項創新技術，專注於透過使用逐層技術精確創建3D結構來生產生物和組織學材料。 3D 生物列印的需求在於其徹底改變再生醫學、醫學和生物工程、解決可移植器官的嚴重短缺、透過精確的組織模型簡化藥物開發以及改善患者治療效果的潛力。應用範圍從創建用於疾病建模的類器官到製造植入和義肢，最終用途包括醫院、研究機構和生物技術公司。影響該市場的關鍵成長要素包括生醫材料的進步、研發資金的增加以及需要創新治療的慢性疾病盛行率的上升。最近的技術創新正在擴大複雜組織結構的生物列印和模仿人體組織的生物墨水的使用的機會。市場動態是由生物列印公司和醫療保健提供者之間合作開發臨床可行的產品推動的，政府以政策和財政獎勵形式的支持正在推動進一步擴張。然而，其局限性包括高製造成本、可擴展性問題、道德問題以及阻礙快速商業化的嚴格監管框架。一個重要的障礙是實現生物列印組織的血管生成和長期功能的技術難度。應對這些挑戰需要引導創新，開發多材料和多細胞生物列印能力，改進生物墨水配方，並提高生物列印過程的自動化程度。此外，涉及生物工程師、材料科學家和醫學專業人員的跨學科研究對於該領域的進步至關重要。雖然組織工程、基因編輯整合和個人化醫療框架開發等新興市場為成長提供了肥沃的土壤，但學術界和工業界必須為市場擴張創造有利的環境，促進工業界和監管機構之間的合作至關重要。該市場正處於起步階段，但正在快速成長，持續的創新和投資是抓住這段變革時期時期潛在機會的關鍵。

主要市場統計
基準年[2023] 17.9億美元
預計年份 [2024] 21.4億美元
預測年份 [2030] 63.9億美元
複合年成長率（%） 19.89%

市場動態：揭示快速發展的 3D 生物列印市場的關鍵市場洞察

供需的動態交互作用正在改變 3D 生物列印市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 對疾病建模和組織工程的需求不斷成長
    • 藥物和錠劑研究中擴大採用 3D 生物列印
  • 市場限制因素
    • 對合適印刷材料的可擴展性和可得性的擔憂
  • 市場機會
    • 增加為博士學術計劃提供的研究經費
    • 3D 生物列印機和生物材料的爆炸性進步
  • 市場挑戰
    • 需要資金進行細胞生物學研究

波特五力：駕馭 3D 生物列印市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 3D 生物列印市場的外部影響

外部宏觀環境因素在塑造 3D 生物列印市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解 3D 生物列印市場的競爭格局

對 3D 生物列印市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣3D生物列印市場供應商績效評估

FPNV 定位矩陣是評估 3D 生物列印市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了 3D 生物列印市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對 3D 生物列印市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對疾病模型和組織工程的需求不斷成長
      • 藥物和錠劑研究中擴大採用 3D 生物列印
    • 抑制因素
      • 對合適印刷材料的擴充性和可用性的擔憂
    • 機會
      • 增加為博士學術計劃提供的研究經費
      • 3D 生物列印機和生醫材料的爆炸性進步
    • 任務
      • 進行細胞生物學研究需要大量資金
  • 市場區隔分析
    • 組成部分：擴大可適應各種應用的 3D 生物列印機的使用
    • 最終用戶：3D生物列印在製藥和生物技術公司中的使用正在蓬勃發展
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第 6 章 3D 生物列印市場：按組成部分

  • 3D生物列印機
  • 生物墨水

第 7 章 3D 生物列印市場：依技術分類

  • 擠壓法生物列印
  • 基於噴墨的生物列印
  • 雷射輔助生物列印

第 8 章 3D 生物列印市場：依最終用戶分類

  • 製藥和生物技術公司
  • 調查機構

第9章美洲3D生物列印市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太3D生物列印市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的3D生物列印市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Readyly3D推出先進的生物墨水，可精確列印複雜組織
    • BIO INX 與 Rousselot 合作推進 3D 生物列印材料
    • Nexa3D 透過收購 Essentium 擴大市場規模
  • 戰略分析和建議

公司名單

  • 3D BioFibR
  • 3D Bioprinting Solutions
  • 3D Systems Corporation
  • Advanced Solutions, Inc.
  • Aspect Biosystems Ltd.
  • Avay Biosciences Private Limited
  • Axiom Space, Inc.
  • Axolotl Biosystems Ltd.
  • BICO Group AB
  • Brinter Inc.
  • Cellbricks GmbH
  • CollPlant Biotechnologies Ltd.
  • Cyfuse Biomedical KK
  • Desktop Metal, Inc.
  • Fluicell AB
  • FluidForm, Inc.
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • GeSiM
  • Inventia Life Science Pty Ltd.
  • Medprin Regenerative Medical Technologies Co., Ltd.
  • Merck KGaA
  • Organovo Holdings Inc.
  • Pandorum Technologies Pvt. Ltd.
  • Precise Bio Inc.
  • Prellis Biologics
  • PrintBio, Inc
  • REGEMAT 3D SL
  • regenHU Ltd.
  • Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd.
  • ROKIT Healthcare Inc.
  • TheWell Bioscience Inc.
  • UPM-Kymmene Corporation
  • UpNano GmbH
Product Code: MRR-43649B5EE3C4

The 3D Bioprinting Market was valued at USD 1.79 billion in 2023, expected to reach USD 2.14 billion in 2024, and is projected to grow at a CAGR of 19.89%, to USD 6.39 billion by 2030.

3D bioprinting is an innovative technology focused on the precise creation of three-dimensional structures using a layer-by-layer method to produce biological and tissue-like materials. Defined by its potential to revolutionize regenerative medicine, pharmaceuticals, and bioengineering, the necessity of 3D bioprinting arises from its ability to address critical shortages in transplantable organs, streamline drug development with accurate tissue models, and customize patient-specific treatments. Its applications span from fabricating organoids for disease modeling to crafting implants and prosthetics, with end-use segments including hospitals, research institutions, and biotechnology companies. Key growth factors influencing this market include advancements in biomaterials, increased funding for R&D, and the rising prevalence of chronic diseases necessitating innovative treatments. Recent technological breakthroughs have expanded opportunities in bioprinting complex tissue structures and using bioinks mimicking human tissues. Market dynamics are propelled by collaborations between bioprinting firms and healthcare providers to develop clinically viable products, while governmental support in the form of policies and financial incentives facilitates further expansion. However, limitations include high manufacturing costs, scalability issues, ethical concerns, and stringent regulatory frameworks that challenge rapid commercialization. A significant barrier remains the technical difficulty in achieving vascularization and long-term functionality of bioprinted tissues. Addressing these challenges involves steering innovation towards developing multi-material and multicellular bioprinting capabilities, refining bioink formulations, and enhancing automation in bioprinting processes. Furthermore, interdisciplinary research involving bioengineers, material scientists, and medical practitioners is crucial for advancing this field. Emerging areas such as tissue engineering, gene editing integration, and the development of personalized medicine frameworks offer fertile ground for growth, while fostering collaboration among academia, industry, and regulatory bodies is essential to nurture a favorable environment for market expansion. With the market in a nascent yet rapidly growing stage, continuous innovation and investment are key to capturing potential opportunities in this transformative landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.79 billion
Estimated Year [2024] USD 2.14 billion
Forecast Year [2030] USD 6.39 billion
CAGR (%) 19.89%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 3D Bioprinting Market

The 3D Bioprinting Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for disease modeling and tissue engineering
    • Increase in deployment of 3D bioprinting across research of drugs and pills
  • Market Restraints
    • Concern over scalability and availability of suitable printing materials
  • Market Opportunities
    • Increasing research funding provided to doctoral academic projects
    • Proliferation in advancements of 3D bioprinters and biomaterials
  • Market Challenges
    • Capital intensive to perform cell biology research

Porter's Five Forces: A Strategic Tool for Navigating the 3D Bioprinting Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 3D Bioprinting Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 3D Bioprinting Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 3D Bioprinting Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 3D Bioprinting Market

A detailed market share analysis in the 3D Bioprinting Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 3D Bioprinting Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 3D Bioprinting Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 3D Bioprinting Market

A strategic analysis of the 3D Bioprinting Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 3D Bioprinting Market, highlighting leading vendors and their innovative profiles. These include 3D BioFibR, 3D Bioprinting Solutions, 3D Systems Corporation, Advanced Solutions, Inc., Aspect Biosystems Ltd., Avay Biosciences Private Limited, Axiom Space, Inc., Axolotl Biosystems Ltd., BICO Group AB, Brinter Inc., Cellbricks GmbH, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal, Inc., Fluicell AB, FluidForm, Inc., FUJIFILM Corporation, GE HealthCare Technologies Inc., GeSiM, Inventia Life Science Pty Ltd., Medprin Regenerative Medical Technologies Co., Ltd., Merck KGaA, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Precise Bio Inc., Prellis Biologics, PrintBio, Inc, REGEMAT 3D S.L., regenHU Ltd., Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd., ROKIT Healthcare Inc., TheWell Bioscience Inc., UPM-Kymmene Corporation, and UpNano GmbH.

Market Segmentation & Coverage

This research report categorizes the 3D Bioprinting Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across 3D Bioprinters and Bioinks.
  • Based on Technology, market is studied across Extrusion-based Bioprinting, Inkjet-based Bioprinting, and Laser-assisted Bioprinting.
  • Based on End-user, market is studied across Pharmaceutical & Biotechnology Companies and Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for disease modeling and tissue engineering
      • 5.1.1.2. Increase in deployment of 3D bioprinting across research of drugs and pills
    • 5.1.2. Restraints
      • 5.1.2.1. Concern over scalability and availability of suitable printing materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing research funding provided to doctoral academic projects
      • 5.1.3.2. Proliferation in advancements of 3D bioprinters and biomaterials
    • 5.1.4. Challenges
      • 5.1.4.1. Capital intensive to perform cell biology research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Proliferating utilization of the 3D bioprinters capable of adapting to a range of applications
    • 5.2.2. End-user: Burgeoning usage of the 3D bioprinting across the pharmaceutical & biotechnology companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. 3D Bioprinting Market, by Component

  • 6.1. Introduction
  • 6.2. 3D Bioprinters
  • 6.3. Bioinks

7. 3D Bioprinting Market, by Technology

  • 7.1. Introduction
  • 7.2. Extrusion-based Bioprinting
  • 7.3. Inkjet-based Bioprinting
  • 7.4. Laser-assisted Bioprinting

8. 3D Bioprinting Market, by End-user

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Research Organizations

9. Americas 3D Bioprinting Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific 3D Bioprinting Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa 3D Bioprinting Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Readily3D Unveils Advanced Bio-Inks for Precision 3D Bioprinting of Complex Tissues
    • 12.3.2. BIO INX Partners with Rousselot for Advancements in 3D Bioprinting Materials
    • 12.3.3. Nexa3D Expands Market Footprint with the Acquisition of Essentium
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3D BioFibR
  • 2. 3D Bioprinting Solutions
  • 3. 3D Systems Corporation
  • 4. Advanced Solutions, Inc.
  • 5. Aspect Biosystems Ltd.
  • 6. Avay Biosciences Private Limited
  • 7. Axiom Space, Inc.
  • 8. Axolotl Biosystems Ltd.
  • 9. BICO Group AB
  • 10. Brinter Inc.
  • 11. Cellbricks GmbH
  • 12. CollPlant Biotechnologies Ltd.
  • 13. Cyfuse Biomedical K.K.
  • 14. Desktop Metal, Inc.
  • 15. Fluicell AB
  • 16. FluidForm, Inc.
  • 17. FUJIFILM Corporation
  • 18. GE HealthCare Technologies Inc.
  • 19. GeSiM
  • 20. Inventia Life Science Pty Ltd.
  • 21. Medprin Regenerative Medical Technologies Co., Ltd.
  • 22. Merck KGaA
  • 23. Organovo Holdings Inc.
  • 24. Pandorum Technologies Pvt. Ltd.
  • 25. Precise Bio Inc.
  • 26. Prellis Biologics
  • 27. PrintBio, Inc
  • 28. REGEMAT 3D S.L.
  • 29. regenHU Ltd.
  • 30. Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd.
  • 31. ROKIT Healthcare Inc.
  • 32. TheWell Bioscience Inc.
  • 33. UPM-Kymmene Corporation
  • 34. UpNano GmbH

LIST OF FIGURES

  • FIGURE 1. 3D BIOPRINTING MARKET RESEARCH PROCESS
  • FIGURE 2. 3D BIOPRINTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL 3D BIOPRINTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. 3D BIOPRINTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. 3D BIOPRINTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. 3D BIOPRINTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL 3D BIOPRINTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. 3D BIOPRINTING MARKET DYNAMICS
  • TABLE 7. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL 3D BIOPRINTING MARKET SIZE, BY 3D BIOPRINTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL 3D BIOPRINTING MARKET SIZE, BY BIOINKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL 3D BIOPRINTING MARKET SIZE, BY EXTRUSION-BASED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL 3D BIOPRINTING MARKET SIZE, BY INKJET-BASED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL 3D BIOPRINTING MARKET SIZE, BY LASER-ASSISTED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL 3D BIOPRINTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL 3D BIOPRINTING MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. 3D BIOPRINTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. 3D BIOPRINTING MARKET, FPNV POSITIONING MATRIX, 2023